2025 Annual Report of Independent Director of Yili Chuaning Biotechnology Co., Ltd.
As the independent director of Yili Chuaning Biotechnology Co., Ltd. (hereinafter referred to as "the Company"), I, Cao Yali, have strictly fulfilled my duties in accordance with the Company Law of the People's Republic of China, the Securities Law of the People's Republic of China, the Articles of Association, and the Management Measures for Independent Directors of Listed Companies, among other relevant regulations. With a diligent and responsible work attitude, I actively attended relevant meetings, voted in accordance with the law, effectively promoted the standardized operation of the Company, and fully played the role of an independent director. The report on my performance for 2025 is as follows:
I. Basic Information
(1) Personal Resume
Born in 1975, I am a Chinese national with no permanent residency abroad, a member of the Communist Party of China, and hold a doctoral degree. In recent years, I have led over 10 provincial and ministerial-level research projects, including 4 National Natural Science Foundation projects, published multiple SCI papers in important international academic journals, and have been granted 16 Chinese invention patents. I received the First Prize for Scientific and Technological Progress from the Xinjiang Uygur Autonomous Region in 2007 and 2013, and the Excellent Paper Award in Natural Science in 2006, 2010, 2014, 2016, and 2018. I was awarded the 9th Xinjiang Youth Science and Technology Award in 2019. I currently serve as an independent director of the Company, a professor at the School of Chemistry, Xinjiang University, and a doctoral supervisor. I have obtained the independent director qualification certificate issued by the Shenzhen Stock Exchange.
(2) Independence Declaration
- Neither I nor my immediate family members or major social relationships hold any position in the Company or its subsidiaries, nor do we directly or indirectly hold more than 1% of the Company's issued shares, are not among the top ten shareholders, and do not hold positions in entities or companies that directly or indirectly hold more than 5% of the Company's issued shares or are among the top five shareholders. I do not hold any position in the actual controller of the Company or its subsidiaries.
- I have not provided financial, legal, consulting, or other services to the Company and its controlling shareholders or their respective subsidiaries, nor have I received any undisclosed additional benefits from the Company or its major shareholders or related parties.
- I do not hold any position in the Company other than that of an independent director, nor do I hold any position in the Company's major shareholders. I have no other significant relationships that could affect my independent and objective judgment. Therefore, there are no circumstances that affect the independence of the Company.
II. Performance of Duties
(1) Board of Directors and Shareholders' Meetings
Board of Directors: In 2025, the Company held 5 board meetings, and I attended all 5, actively participating in the discussions without any absences or proxy attendance, voting in favor of all proposals.
Shareholders' Meetings: I attended 3 shareholders' meetings, listened to shareholders' opinions, and supervised the compliance of the resolution procedures.
(2) Special Committees
In 2025, the Company held 6 meetings of the Audit Committee, 1 meeting of the Remuneration and Assessment Committee, and 1 meeting of the Strategy and ESG Committee. I actively participated in all these meetings without any absences or proxy attendance, and all proposals were approved.
(3) Special Meetings of Independent Directors
In 2025, the Company held 2 special meetings for independent directors, and I personally attended both without any absences or proxy attendance, approving all proposals.